Prospective Longitudinal Substance Use Patterns in Patients Preparing for Hepatitis C Treatment

References

• American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association.
   Google Scholar
• Basseri, B., Yamini, D., Chee, G., Enayati, P. D., Tran, T., & Poordad, F. (2010). Comorbidities associated with the increasing burden of hepatitis C infection. Liver International, 30(7), 1012–1018. doi:10.1111/j.1478-3231.2010.02235.x
   PubMed Web of Science ®Google Scholar
• Boscarino, J. A., Lu, M., Moorman, A. C., Gordon, S. C., Rupp, L. B., Spradling,  , … Holmberg, S. D. (2015). Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The Chronic Hepatitis Cohort Study (CHeCS). Hepatology, 61(3), 802–811. doi:10.1002/hep.27422
   PubMed Web of Science ®Google Scholar
• Cellar, D. F., Voster, D., Fetters, R., Twitchell, E., Harper, G. W., & Scott, C. (2016). Personality, coping, and well-being for people living with chronic hepatitis C. Psychological Reports, 118(2), 649–667. doi:10.1177/0033294115625557
   PubMed Web of Science ®Google Scholar
• Chew, K. W., Bhattacharya, D., McGinnis, K. A., Horwich, T. B., Tseng, C. H., Currier, J. S., & Butt, A. A. (2015). Short communication: Coronary heart disease risk by Framingham risk score in hepatitis C and HIV/hepatitis C-coinfected persons. AIDS Research and Human Retroviruses, 31(7), 718–722. doi:10.1089/AID.2014.0284
   PubMed Web of Science ®Google Scholar
• Choi, J. (2012). Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: Pathogenic interactions and therapeutic considerations. Free Radical Biology and Medicine, 52(7), 1135–1150. doi:10.1016/j.freeradbiomed.2012.01.008
   PubMed Web of Science ®Google Scholar
• Costiniuk, C. T., Brunet, L., Rollet-Kurhajec, K. C., Cooper, C. L., Walmsley, S. L., Gill, M. J., … Klein, M. B. (2016). Tobacco smoking is not associated with accelerated liver disease in human immunodeficiency virus-hepatitis C coinfection: A longitudinal cohort analysis. Open Forum Infectious Diseases, 3(2), ofw050. doi:10.1093/ofid/ofw050
   PubMed Web of Science ®Google Scholar
• Cucciare, M. A., Cheung, R. C., & Rongey, C. (2015). Treating substance use disorders in patients with hepatitis C. Addiction, 110(7), 1057–1059. doi:10.1111/add.12893
   PubMed Web of Science ®Google Scholar
• Drumright, L. N., Hagan, H., Thomas, D. L., Latka, M. H., Golub, E. T., Garfein, R. S., … Strathdee, S. A. (2011). Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. Journal of Hepatology, 55(1), 45–52. doi:10.1016/j.jhep.2010.10.028
   PubMed Web of Science ®Google Scholar
• Jeng, J. E., Tsai, H. R., Chuang, L. Y., Tsai, J. F., Lin, Z. Y., Hsieh, M. Y., … Chang, J. G. (2009). Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore), 88(6), 349–357. doi:10.1097/MD.0b013e3181c10477
   PubMed Web of Science ®Google Scholar
• Kertesz, S. G., Austin, E. L., Holmes, S. K., Pollio, D. E., Schumacher, J. E., White, B., & Lukas, C. V. (2014). Making housing first happen: Organizational leadership in VA's expansion of permanent supportive housing. Journal of General Internal Medicine, 29( Suppl. 4), 835–844. doi:10.1007/s11606-014-3025-4
   PubMedGoogle Scholar
• Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., … Goodman, Z. D. (2009). Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology, 136(1), 138–148. doi:10.1053/j.gastro.2008.09.014
   PubMed Web of Science ®Google Scholar
• Morris, S. B., & DeShon, R. P. (2002). Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods, 7(1), 105–125.
   PubMed Web of Science ®Google Scholar
• North, C. S., Pollio, D. E., Sims, O. T., Jain, M. K., Brown, G. R., Downs, D. L., … Hong, B. A. (2017). An effectiveness study of group psychoeducation for hepatitis C patients in community clinics. European Journal of Gastroenterology and Hepatology, 29(6), 679–685. doi:10.1097/MEG.0000000000000860
   PubMed Web of Science ®Google Scholar
• North, C. S., Sims, O., Hong, B. A., Jain, M. K., Brown, G., Lisker-Melman, M., & Pollio, D. E. (2014). An empirical study of alcohol consumption by patients considering HCV treatment. American Journal of Drug and Alcohol Abuse, 40(6), 484–489. doi:10.3109/00952990.2014.945592
   PubMed Web of Science ®Google Scholar
• Osna, N. A., Ganesan, M., & Kharbanda, K. K. (2015). Hepatitis C, innate immunity and alcohol: Friends or foes? Biomolecules, 5(1), 76–94. doi:10.3390/biom5010076
   PubMed Web of Science ®Google Scholar
• Shuter, J., Litwin, A. H., Sulkowski, M. S., Feinstein, A., Bursky-Tammam, A., Maslak, S., … Norton, B. (2016). Cigarette smoking behaviors and beliefs in persons living with hepatitis C. Nicotine and Tobacco Research, 19(7), 836–844. doi:10.1093/ntr/ntw212
   Web of Science ®Google Scholar
• Sims, O. T., Maynard, Q. R., & Melton, P. A. (2016). Behavioral interventions to reduce alcohol use among patients with hepatitis C: A systematic review. Social Work in Public Health, 31(6), 565–573. doi:10.1080/19371918.2016.1160346
   PubMed Web of Science ®Google Scholar
• Sims, O. T., Pollio, D. E., Hong, B. A., Jain, M. K., Brown, G. R., & North, C. S. (2016). An assessment of concurrent drug and alcohol use among patients seeking treatment for hepatitis C. Annals of Clinical Psychiatry, 28(1), 31–36.
   PubMed Web of Science ®Google Scholar
• Soeda, J., Morgan, M., McKee, C., Mouralidarane, A., Lin, C., Roskams, T., & Oben, J. A. (2012). Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochemical and Biophysical Research Communications, 417(1), 17–22. doi:10.1016/j.bbrc.2011.10.151
   PubMed Web of Science ®Google Scholar
• Stewart, B. J., Mikocka-Walus, A. A., Harley, H., & Andrews, J. M. (2012). Help-seeking and coping with the psychosocial burden of chronic hepatitis C: A qualitative study of patient, hepatologist, and counsellor perspectives. International Journal of Nursing Studies, 49(5), 560–569. doi:10.1016/j.ijnurstu.2011.11.004
   PubMed Web of Science ®Google Scholar
• Strauss, E., Porto-Ferreira, F. A., de Almeida-Neto, C., & Teixeira, M. C. (2014). Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself. Clinics and Research in Hepatology and Gastroenterology, 38(1), 40–45. doi:10.1016/j.clinre.2013.08.008
   PubMed Web of Science ®Google Scholar
• Taylor, A. L., Denniston, M. M., Klevens, R. M., McKnight-Eily, L. R., & Jiles, R. B. (2016). Association of hepatitis C virus with alcohol use among U.S. adults: NHANES 2003–2010. American Journal of Preventive Medicine, 51(2), 206–215. doi:10.1016/j.amepre.2016.02.033
   PubMed Web of Science ®Google Scholar
• Tsai, J., Ford, E. S., Li, C., & Zhao, G. (2012). Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Addictive Behaviors, 37(1), 78–84. doi:10.1016/j.addbeh.2011.09.002
   PubMed Web of Science ®Google Scholar
• Whitehead, N. E., Hearn, L., Trenz, R. C., Burrell, L. E., & Latimer, W. W. (2014). Age cohort differences in illicit drug use and hepatitis C among African American substance users. Journal of Addictive Diseases, 33(4), 314–321. doi:10.1080/10550887.2014.969605
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2004). The Composite International Diagnostic Interview– Substance Abuse Module. Geneva, Switzerland: World Health Organization. Retrieved from http://www.hcp.med.harvard.edu/wmhcidi/about.php
   Google Scholar
• Younossi, Z. M., Zheng, L., Stepanova, M., Venkatesan, C., & Mir, H. M. (2013). Moderate, excessive or heavy alcohol consumption: Each is significantly associated with increased mortality in patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics, 37(7), 703–709. doi:10.1111/apt.12265
   PubMed Web of Science ®Google Scholar
• Zhao, L., Li, F., & Taylor, E. W. (2013). Can tobacco use promote HCV-induced miR-122 hijacking and hepatocarcinogenesis? Medical Hypotheses, 80(2), 131–133. doi:10.1016/j.mehy.2012.11.009
   PubMed Web of Science ®Google Scholar
• Zimmermann, T., Hueppe, D., Mauss, S., Buggisch, P., Pfeiffer-Vornkahl, H., Grimm, D., … Alshuth, U. (2016). Effects of smoking on pegylated interferon alpha 2a and first generation protease inhibitor-based antiviral therapy in naive patients infected with hepatitis C virus genotype 1. Journal of Gastrointestinal and Liver Diseases, 25(1), 15–24.
   PubMed Web of Science ®Google Scholar